Distinct gut microbiome features characterize Fasciola hepatica infection and predict triclabendazole treatment outcomes in Peruvian patients

BackgroundFasciola hepatica, a globally distributed helminth, causes fasciolosis, a disease with significant health and economic impacts. Variability in triclabendazole (TCBZ) efficacy and emerging resistance are remaining challenges. Evidence suggests that the gut microbiome influences host-helmint...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Frontiers in Cellular and Infection Microbiology
المؤلفون الرئيسيون: Giljae Lee, Bruce A. Rosa, Martha V. Fernandez-Baca, John Martin, Rodrigo A. Ore, Pedro Ortiz, Miguel M. Cabada, Makedonka Mitreva
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Frontiers Media S.A. 2025-03-01
الموضوعات:
الوصول للمادة أونلاين:https://www.frontiersin.org/articles/10.3389/fcimb.2025.1555171/full

مواد مشابهة